The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence
Open accessAbstract
Accumulating evidence implicates small vessel cerebrovascular disease, visualized as white matter hyperintensities (WMH) on T2-weighted MRI, in the pathogenesis and diagnosis of Alzheimer's disease (AD). Cross-sectional volumetric measures of WMH, particularly in the parietal lobes, are associated with increased risk of AD. In the current study, we sought to determine whether the longitudinal regional progression of WMH predicts incident AD above-and-beyond traditional radiological markers of neurodegeneration (i.e., hippocampal atrophy, cortical thickness). Three hundred three non-demented older adults (mean age = 79.24±5.29) received high-resolution MRI at baseline and then again 4.6 years (SD=1.01) later. Over the follow-up interval 26 participants progressed to AD. Using structural equation modeling (SEM), we calculated latent difference scores of parietal/non-parietal WMH, hippocampus volumes, and cortical thickness values in AD-related regions. Within the SEM framework, we determined whether baseline or change scores or both predicted AD conversion, while controlling for several time-invariant relevant variables. Smaller baseline hippocampus volume, change in hippocampus volume (i.e., atrophy), higher baseline parietal lobe WMH, and increasing parietal lobe WMH volume but not WMH in other regions or measures of cortical thickness, independently predicted progression to AD. The findings provide strong evidence that regionally accumulating WMH, in addition to degenerative changes in the medial temporal lobe, predict AD onset in addition to hallmark neurodegenerative changes typically associated with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Metabolic neuroimaging studies consistently suggest a diminution in parietal regions (Ishii, et al., 2005,Jagust, et al., 2002), and the earliest deposition of amyloid plaque pathology occurs in posterior association areas(Braak and Braak, 1991,Braak and Braak, 1996).”
BackgroundRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Latent Variable Modeling of Differences and Changes with Longitudinal Data
McArdle, J. J. (2009) · Annual Review of Psychology · doi:10.1146/annurev.psych.60.110707.163612 · Cited by 1,952 · cited 2×
“, mean change, interindividual variability in change, relationship between initial value, and change) can be modeled as explicit parameters (McArdle, 2009).”
BackgroundAlzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., Grodstein, F., Wright, C. I., Blacker, D., Rosas, H. D., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn113 · Cited by 1,153
Frequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059
A pathophysiological framework of hippocampal dysfunction in ageing and disease
Small, S. A., Schobel, S. A., Buxton, R. B., Witter, M. P., & Barnes, C. A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3085 · Cited by 926
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan
Tang, M.-X., Cross, P., Andrews, H., Jacobs, D. M., Small, S., Bell, K., Merchant, C., Lantigua, R., Costa, R., Stern, Y., et al. (2001) · Neurology · doi:10.1212/wnl.56.1.49 · Cited by 722
Self-citationEvolution of the neuropathology of Alzheimer's disease
Braak, H., & Braak, E. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05866.x · Cited by 710 · cited 1×
“Metabolic neuroimaging studies consistently suggest a diminution in parietal regions (Ishii, et al., 2005,Jagust, et al., 2002), and the earliest deposition of amyloid plaque pathology occurs in posterior association areas(Braak and Braak, 1991,Braak and Braak, 1996).”
BackgroundKhan, U. A., Liu, L., Provenzano, F. A., Berman, D. E., Profaci, C. P., Sloan, R., Mayeux, R., Duff, K. E., & Small, S. A. (2014) · Nature Neuroscience · doi:10.1038/nn.3606 · Cited by 561
Self-citationVinters, H. V., & Gilbert, J. J. (1983) · Stroke · doi:10.1161/01.str.14.6.924 · Cited by 504
Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort
Dufouil, C., de Kersaint–Gilly, A., Besançon, V., Levy, C., Auffray, E., Brunnereau, L., Alpérovitch, A., & Tzourio, C. (2001) · Neurology · doi:10.1212/wnl.56.7.921 · Cited by 465
Report of the second dementia with Lewy body international workshop: Diagnosis and treatment
McKeith, I. G., Perry, E. K., & Perry, R. H. (1999) · Neurology · doi:10.1212/wnl.53.5.902 · Cited by 460
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., & DeCarli, C. S. (2006) · Neurology · doi:10.1212/01.wnl.0000249119.95747.1f · Cited by 434 · cited 1×
“There have been several previous cross-sectional reports showing elevated WMH among individuals with and at risk for AD (Brickman, 2013; Brickman et al., 2009; Hogervorst et al., 2002; Makedonov et al., 2013; Provenzano et al., 2013; Yoshita et al., 2006), although with some inconsistencies regarding the regional dist…”
ResultMRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study
Whitwell, J. L., Josephs, K. A., Murray, M. E., Kantarci, K., Przybelski, S. A., Weigand, S. D., Vemuri, P., Senjem, M. L., Parisi, J. E., Knopman, D. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324924.91351.7d · Cited by 376
Stern, Y. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290035009 · Cited by 369
Self-citationPIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302 · cited 1×
“White matter hyperintensities are typically considered to be a nonspecific marker of cerebrovascular diseases associated with aging and not AD specifically, but beta amyloid and tau pathology can be described similarly; both are common in aging and certainly occur among older adults without any clinical evidence of ne…”
BackgroundBrain Morphology in Older African Americans, Caribbean Hispanics, and Whites From Northern Manhattan
Brickman, A. M., Schupf, N., Manly, J. J., Luchsinger, J. A., Andrews, H., Tang, M. X., Reitz, C., Small, S. A., Mayeux, R., DeCarli, C., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1053 · Cited by 268
Self-citationCerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias
Yarchoan, M., Xie, S. X., Kling, M. A., Toledo, J. B., Wolk, D. A., Lee, E. B., Van Deerlin, V., Lee, V. M. Y., Trojanowski, J. Q., & Arnold, S. E. (2012) · Brain · doi:10.1093/brain/aws271 · Cited by 262
Brickman, A. M., Provenzano, F. A., Muraskin, J., Manly, J. J., Blum, S., Apa, Z., Stern, Y., Brown, T. R., Luchsinger, J. A., & Mayeux, R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1527 · Cited by 257
Self-citationCarmichael, O. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.284 · Cited by 248
Neuropathologic basis of white matter hyperintensity accumulation with advanced age
Erten-Lyons, D., Woltjer, R., Kaye, J., Mattek, N., Dodge, H. H., Green, S., Tran, H., Howieson, D. B., Wild, K., & Silbert, L. C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a43e45 · Cited by 225
Long-term Blood Pressure Fluctuation and Cerebrovascular Disease in an Elderly Cohort
Brickman, A. M., Reitz, C., Luchsinger, J. A., Manly, J. J., Schupf, N., Muraskin, J., DeCarli, C., Brown, T. R., & Mayeux, R. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.70 · Cited by 204
Self-citationProvenzano, F. A., Muraskin, J., Tosto, G., Narkhede, A., Wasserman, B. T., Griffith, E. Y., Guzman, V. A., Meier, I. B., Zimmerman, M. E., Brickman, A. M., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1321 · Cited by 192
Self-citationCoevolution of white matter hyperintensities and cognition in the elderly
Maillard, P., Carmichael, O., Fletcher, E., Reed, B., Mungas, D., & DeCarli, C. (2012) · Neurology · doi:10.1212/wnl.0b013e3182617136 · Cited by 172 · cited 1×
“The expansion of WMH severity over a 4-year period was associated with worsening cognitive functioning in a sample of 150 older adults with AD, mild cognitive impairment, or without neurologic disease (Maillard et al., 2012), and acceleration of WMH accumulation has been observed to precede in presymptomatic phase tha…”
BackgroundCapizzano, A. A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.019273 · Cited by 163
Brickman, A. M., Honig, L. S., Scarmeas, N., Tatarina, O., Sanders, L., Albert, M. S., Brandt, J., Blacker, D., & Stern, Y. (2008) · Archives of Neurology · doi:10.1001/archneur.65.9.1202 · Cited by 160
Self-citationHogervorst, E., Ribeiro, H. M., Molyneux, A., Budge, M., & Smith, A. D. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.787 · Cited by 159
Vascular burden and Alzheimer disease pathologic progression
Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b9d · Cited by 156
Self-citationContemplating Alzheimer’s Disease and the Contribution of White Matter Hyperintensities
Brickman, A. M. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0415-7 · Cited by 153
Self-citationStructural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter?
Brickman, A. M., Muraskin, J., & Zimmerman, M. E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/ambrickman · Cited by 145
Self-citationTrajectory of white matter hyperintensity burden preceding mild cognitive impairment
Silbert, L. C., Dodge, H. H., Perkins, L. N., Sherbakov, L. O., Lahna, D. L., Erten‐Lyons, D., Woltjer, R. L., Shinto, L. H., & Kaye, J. A. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661f2b · Cited by 128
Brain function and cognition in a community sample of elderly Latinos
Jagust, W. J., Eberling, J. L., Wu, C. C., Finkbeiner, A., Mungas, D., Valk, P. E., & Haan, M. N. (2002) · Neurology · doi:10.1212/wnl.59.3.378 · Cited by 119
Siedlecki, K. L., Manly, J. J., Brickman, A. M., Schupf, N., Tang, M., & Stern, Y. (2010) · Neuropsychology · doi:10.1037/a0017515 · Cited by 119
Self-citationSubclinical cerebrovascular disease in mild cognitive impairment
Luchsinger, J. A., Brickman, A. M., Reitz, C., Cho, S., Schupf, N., Manly, J. J., Tang, M. ‐., Small, S. A., Mayeux, R. P., DeCarli, C. S., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b1636a · Cited by 100
Self-citationIshii, K., Sasaki, H., Kono, A. K., Miyamoto, N., Fukuda, T., & Mori, E. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1740-5 · Cited by 97
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old
Polvikoski, T. M., van Straaten, E. C. W., Barkhof, F., Sulkava, R., Aronen, H. J., Niinistö, L., Oinas, M., Scheltens, P., Erkinjuntti, T., & Kalaria, R. N. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d6f9 · Cited by 88
Quantitative approaches for assessment of white matter hyperintensities in elderly populations
Brickman, A. M., Sneed, J. R., Provenzano, F. A., Garcon, E., Johnert, L. C., Muraskin, J., Yeung, L., Zimmerman, M. E., & Roose, S. P. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.03.007 · Cited by 88
Self-citationBrickman, A. M., Schupf, N., Manly, J. J., Stern, Y., Luchsinger, J. A., Provenzano, F. A., Narkhede, A., Razlighi, Q. R., Collins‐Praino, L. E., Artéro, S., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.07.155 · Cited by 88
Self-citationWhite Matter Predictors of Cognitive Functioning in Older Adults
Meier, I. B., Manly, J. J., Provenzano, F. A., Louie, K. S., Wasserman, B. T., Griffith, E. Y., Hector, J. T., Allocco, E. R., & Brickman, A. M. (2012) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712000227 · Cited by 64
Self-citationMakedonov, I., Black, S. E., & MacIntosh, B. J. (2013) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03785.x · Cited by 62
Wiegman, A. F., Meier, I. B., Provenzano, F. A., Schupf, N., Manly, J. J., Stern, Y., Luchsinger, J. A., & Brickman, A. M. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12568 · Cited by 8
Self-citationBrickman, A. M., Narkhede, A., Schupf, N., Luchsinger, J. A., Manly, J. J., Stern, Y., Provenzano, F. A., Artéro, S., Akbaraly, T. N., Ritchie, K. A., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.500 · Cited by 3
Self-citation
Cited by
White matter hyperintensities, cognitive impairment and dementia: an update
Prins, N. D., & Scheltens, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.10 · Cited by 1,284
White matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0515-3 · Cited by 723
“[18, 19, 21], the rate of cognitive decline among individuals with prevalent AD [78], and is associated with genetic risk factors for late onset AD [20].”
Self-citationLee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24647 · Cited by 542
Babulal, G. M., Quiroz, Y. T., Albensi, B. C., Arenaza‐Urquijo, E., Astell, A. J., Babiloni, C., Bahar‐Fuchs, A., Bell, J., Bowman, G. L., Brickman, A. M., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.009 · Cited by 528
“[217] Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al.”
BackgroundSelf-citationWhite matter hyperintensities and imaging patterns of brain ageing in the general population
Habes, M., Erus, G., Toledo, J. B., Zhang, T., Bryan, N., Launer, L. J., Rosseel, Y., Janowitz, D., Doshi, J., Van der Auwera, S., et al. (2016) · Brain · doi:10.1093/brain/aww008 · Cited by 422
Metadata
- Authors
- Brickman, A. M., Zahodne, L. B., Guzman, V. A., Narkhede, A., Meier, I. B., Griffith, E. Y., Provenzano, F. A., Schupf, N., Manly, J. J., Stern, Y., Luchsinger, J. A., & Mayeux, R.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 36
- Issue
- 1
- Pages
- 27-32
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2017146561
- Cited by
- 255
- References
- 46
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.